Latest News about SDGR

Recent news which mentions SDGR

< Previous 1 2 3 4 5 6 Next >

Earnings Scheduled For February 28, 2023

February 28, 2023

3 AI Stocks to Buy for the Future of Automation

February 17, 2023

Citigroup Maintains Buy Rating for Schrodinger: Here's What You Need To Know

January 31, 2023

4 Analysts Have This to Say About Schrodinger

January 31, 2023

Why These 7 Healthcare Stocks Could Soar in 2023

January 02, 2023

7 Drug Stocks That Will Soar in 2023

December 22, 2022

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session

December 13, 2022

Stocks That Hit 52-Week Lows On Monday

December 05, 2022

Stocks That Hit 52-Week Lows On Friday

December 02, 2022

12 Health Care Stocks Moving In Monday's After-Market Session

November 28, 2022

Stocks That Hit 52-Week Lows On Monday

November 28, 2022

Yelp, Twilio, Atlassian, And Other Big Losers From Friday

November 07, 2022

Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday

November 07, 2022

3 Hypergrowth Stocks That Will Make You a Millionaire by 2027

November 04, 2022

Stocks That Hit 52-Week Lows On Friday

November 04, 2022

Earnings Scheduled For November 3, 2022

November 03, 2022

7 Small-Cap Stock Picks to Beat the September Market Slump

September 15, 2022

Cathie Wood Loads Up $4.6M In Bill Gates-Backed Healthcare Tech Company

August 19, 2022

Geoffrey Porges has been named CFO of Schrodinger Inc. (SDGR). SDGR is currently trading at $28.07 per share.

August 18, 2022

Schrödinger, Inc. (SDGR) Q2 2022 Earnings Call Transcript

August 05, 2022

3 Biotech Stocks to Buy on the Dip

July 21, 2022

The 7 Best Stocks to Buy on a Dip in July

July 14, 2022

Schrödinger's Initial-Stage Cancer Study Gains FDA Clearance

June 28, 2022

Bill Gates Stocks: 7 Top Picks From the Gates Foundation Portfolio

June 13, 2022

Schrödinger, Inc. (SDGR) Q1 2022 Earnings Call Transcript

May 05, 2022

Recap: Schrodinger Q1 Earnings

May 04, 2022

AI Pharma Startup METiS Raises $150 Million. IPO In Sight?

April 12, 2022

Schrödinger New Preclinical Data Supports Development Of Its Wee1 Inhibitor In Cancer Indications

April 12, 2022

The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More

April 12, 2022

3 Hypergrowth Tech Stocks to Buy for Huge Upside Potential

April 07, 2022

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.